Clinical Trials Insight: 700024039

Trial Profile

Clinical Trials Insight: 700024039

Not stated
Phase of Trial: Phase II

Latest Information Update: 26 Jan 2010

At a glance

  • Drugs Bafetinib (Primary)
  • Indications Chronic myeloid leukaemia
  • Focus Registrational; Therapeutic Use
  • Sponsors INNOVIVE Pharmaceuticals
  • Most Recent Events

    • 26 Jan 2010 Status changed from planning to unconfirmed.
    • 22 Jun 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top